Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.27B |
| 2 |
SNDK
Sandisk
SNDK
|
+$674M |
| 3 |
Credo Technology Group
CRDO
|
+$476M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$452M |
| 5 |
Vertiv
VRT
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.98B |
| 2 |
Amazon
AMZN
|
+$1.25B |
| 3 |
Shopify
SHOP
|
+$1.08B |
| 4 |
Edwards Lifesciences
EW
|
+$1.07B |
| 5 |
Microsoft
MSFT
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.11% |
| 2 | Communication Services | 13.94% |
| 3 | Consumer Discretionary | 10.64% |
| 4 | Industrials | 9.08% |
| 5 | Healthcare | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Tandem Diabetes Care
TNDM
$1.49B
| $35.2M | 0.02% |
2,331,429
+672,981
| +41% | +$11.8M |
|
277
Kinder Morgan
KMI
$70.3B
| $34.7M | 0.02% |
1,084,392
-12,276
| -1% | -$396K |
|
278
Energy Transfer Partners
ET
$73.4B
| $34.5M | 0.02% |
1,802,685
+218,646
| +14% | +$4.23M |
|
279
Exelon
EXC
$45.3B
| $33.3M | 0.02% |
714,778
-1,435,780
| -67% | -$66.4M |
|
280
FirstEnergy
FE
$26.5B
| $33.3M | 0.02% |
+700,736
| New | +$33.3M |
|
281
Benchmark Electronics
BHE
$2.56B
| $33.1M | 0.02% |
+335,616
| New | +$26.8M |
|
282
Horizon Bancorp
HBNC
$1B
| $32.9M | 0.02% |
1,644,321
+38,523
| +2% | +$709K |
|
|
KRMN
283
Karman Holdings
KRMN
$6.04B
| $32.4M | 0.02% |
649,508
-5,372
| -0.8% | -$347K |
|
284
Rocket Lab Corp
RKLB
$41.2B
| $32.4M | 0.02% |
+318,542
| New | +$31.7M |
|
285
Disc Medicine
IRON
$3.07B
| $32.1M | 0.02% |
439,520
-170,862
| -28% | -$11.7M |
|
286
TotalEnergies
TTE
$191B
| $32M | 0.02% |
411,019
-263
| -0.1% | -$23.3K |
|
287
Viavi Solutions
VIAV
$9.02B
| $31.4M | 0.02% |
656,976
-27,504
| -4% | -$1.32M |
|
288
Domino's
DPZ
$11.6B
| $31.3M | 0.02% |
105,800
-94,595
| -47% | -$31.1M |
|
289
Sotera Health
SHC
$5.5B
| $31.3M | 0.02% |
1,764,049
-72,697
| -4% | -$1.15M |
|
290
C.H. Robinson
CHRW
$17.6B
| $31M | 0.02% |
164,740
-108,121
| -40% | -$19.2M |
|
291
AvePoint
AVPT
$2.96B
| $30.7M | 0.02% |
2,738,972
-1,028,609
| -27% | -$10.6M |
|
292
Microchip Technology
MCHP
$39.6B
| $30.3M | 0.02% |
331,860
+84,087
| +34% | +$7.5M |
|
293
SiTime
SITM
$16.8B
| $29.3M | 0.02% |
39,343
-13,164
| -25% | -$8.3M |
|
|
QNT
294
Quantinuum Inc
QNT
$1.84B
| $29.3M | 0.02% |
+358,462
| New | +$23.1M |
|
|
ONC
295
BeOne Medicines Ltd
ONC
$41.5B
| $28.7M | 0.02% |
100,698
-53,767
| -35% | -$15.8M |
|
296
Nicolet Bankshares
NIC
$3.6B
| $28.6M | 0.02% |
172,925
-41,002
| -19% | -$6.05M |
|
|
ORKA
297
Oruka Therapeutics
ORKA
$6.03B
| $28.5M | 0.02% |
299,257
+122,577
| +69% | +$8.17M |
|
298
ConocoPhillips
COP
$157B
| $28.3M | 0.02% |
271,740
-374
| -0.1% | -$44.3K |
|
|
WBI
299
WaterBridge Infrastructure LLC
WBI
$1.74B
| $28.2M | 0.02% |
821,534
+497,611
| +154% | +$14.5M |
|
300
Powell Industries
POWL
$6.66B
| $27.7M | 0.02% |
96,763
+19,981
| +26% | +$5.42M |
|
Similar funds
Jennison Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Jennison Associates held 641 positions worth $167B, up 15% from $145B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates withdrew a net $6.22B in Q2 2026, closing 74 positions and reducing 282 holdings. Its most notable exit was Gilead Sciences, an estimated $176M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in SpaceX worth $1.27B.
- Jennison Associates's largest Q2 2026 buy was SpaceX: 7,448,891 shares worth $1.27B.
- Jennison Associates added most to Credo Technology Group in Q2 2026, an estimated $476M increase.
- Jennison Associates's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.98B.
- Jennison Associates fully exited Gilead Sciences in Q2 2026, selling an estimated $176M.
- Jennison Associates's ten largest holdings make up 45% of its $167B portfolio in Q2 2026.
- Jennison Associates opened 79 new positions and closed 74 in Q2 2026.
- Jennison Associates's portfolio value rose 15% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.